Interações medicamentosas
Blinatumomab + Ethosuximide
Gravidade: Moderada
Blinatumomab and Ethosuximide: moderate interaction.
Última atualização
Para profissionais de saúde — apenas referência. Esta página é um resumo breve, não é aconselhamento médico nem substitui a bula oficial ou o julgamento clínico. Verifique sempre antes de prescrever ou dispensar.
O conteúdo clínico desta página está disponível apenas em inglês.
Resumo
Blinatumomab causes transient cytokine release that can suppress CYP enzymes, potentially raising levels of ethosuximide. The risk is greatest during the first days of treatment cycles.
O que esta interação significa em palavras simples
Blinatumomab and Ethosuximide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Blinatumomab belongs to Oncology; Ethosuximide belongs to Central Nervous System.
Por que acontece
Cytokine-mediated transient suppression of CYP450 enzymes reduces ethosuximide metabolism.
O que fazer
Monitor for ethosuximide toxicity such as drowsiness, nausea and ataxia during the first days of each cycle, and check drug levels if symptomatic.
O que perguntar ao farmacêutico
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Para assinantes do Pro+
Desbloqueie a página completa
Crie uma conta e comece um teste do Pro+ para desbloquear a orientação completa de conduta para Blinatumomab e Ethosuximide, as notas adicionais, os detalhes da evidência e o verificador de interações para uma prescrição completa.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Experimente o Pro+ grátis por 14 dias na web. Sem cartão.
Outras interações de Ethosuximide
- Benzhydrocodone / acetaminophen + Ethosuximide Grave
- Buprenorphine long-acting + Ethosuximide Grave
- Buprenorphine subdermal implant + Ethosuximide Grave
- Buprenorphine transdermal + Ethosuximide Grave
- Calcium / magnesium / potassium / sodium oxybates + Ethosuximide Grave
- Ethosuximide + Fentanyl intranasal Grave
Outras interações de Blinatumomab
- Blinatumomab + Carbamazepine Moderada
- Blinatumomab + Cyclosporin Moderada
- Blinatumomab + Phenytoin Moderada
- Blinatumomab + Quinidine Moderada
- Blinatumomab + Quinine Moderada
- Blinatumomab + Siponimod Moderada
Perguntas frequentes
Can I take Blinatumomab with Ethosuximide?
MediHelp rates the interaction as moderate. Blinatumomab and Ethosuximide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Blinatumomab causes transient cytokine release that can suppress CYP enzymes, potentially raising levels of ethosuximide. The risk is greatest during the first days of treatment cycles.
How serious is the interaction between Blinatumomab and Ethosuximide?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor for ethosuximide toxicity such as drowsiness, nausea and ataxia during the first days of each cycle, and check drug levels if symptomatic.
What other medicines interact with Ethosuximide?
MediHelp also lists interactions of Ethosuximide with, for example, Benzhydrocodone / acetaminophen, Buprenorphine long-acting, Buprenorphine subdermal implant. The full list is on the Ethosuximide page.
Monografias completas, posologia e verificador de interações no app MediHelp
Abra a referência completa, verifique interações entre vários medicamentos e use as ferramentas de posologia no app MediHelp.
